6.250GBp0.00%Mkt Cap: 6.46M GBpP/E: —Last update: 2026-06-01
OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally. The company identifi…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap6.46M GBp
Enterprise Value5.00M GBp
Revenue (TTM)1.15M GBp
Gross Profit331.00K GBp
Net Income (TTM)-1.80M GBp
Revenue/Share0.0110 GBp
Last Price6.250 GBp
Fiscal Year EndDec 2024
MR QuarterJun 2025
Employees10
CountryGB
SectorHealthcare
IndustryBiotechnology
ISINCA68405H1001
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-2.06
EV/Revenue4.35
P/S5.61
P/B0.76
EPS (TTM)-0.04
EPS (Forward)—
52W Range
4.50018% of range14.50
52W High14.50 GBp
52W Low4.500 GBp
Profitability
Gross Margin38.05%
Oper. Margin-257.99%
EBITDA Margin-211.30%
Profit Margin-207.47%
ROE-21.49%
ROA-19.96%
Growth
Revenue Growth101.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.77M GBp
CapEx (TTM)—
FCF Margin-79.33%
FCF Yield-14.14%
Net Debt-1.30M GBp
Net Debt/EBITDA0.53
Balance Sheet
Debt/Equity—
Current Ratio4.61
Quick Ratio3.75
Book Value/Sh0.0820 GBp
Cash/Share0.0130 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:200
Split DateAug 5, 2014
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.103.30M
Float92.81M
Insiders11.53%
Institutions7.74%
Technical
SMA 505.317 (+17.5%)
SMA 2007.391 (-15.4%)
Beta1.80
S&P 52W Chg27.94%
Avg Vol (30d)354.52K
Avg Vol (10d)258.21K
Technical Indicators
RSI (14)80.3
MACD0.1928
MACD Signal0.1037
MACD Hist.+0.0892
BB Upper6.308 GBp
BB Middle5.478 GBp
BB Lower4.647 GBp
BB Width30.31%
ATR (14)0.4363 GBp
Vol Ratio (20d)0.30x